School of Sport and Exercise, Massey University, Wellington, New Zealand.
Med Sci Sports Exerc. 2012 Jan;44(1):57-68. doi: 10.1249/MSS.0b013e3182290371.
This study aimed to determine the effect of postexercise protein-leucine coingestion with CHO-lipid on subsequent high-intensity endurance performance and to investigate candidate mechanisms using stable isotope methods and metabolomics.
In this double-blind, randomized, crossover study, 12 male cyclists ingested a leucine/protein/CHO/fat supplement (LEUPRO 7.5/20/89/22 g · h(-1), respectively) or isocaloric CHO/fat control (119/22 g · h(-1)) 1-3 h after exercise during a 6-d training block (intense intervals, recovery, repeated-sprint performance rides). Daily protein intake was clamped at 1.9 g · kg(-1) · d(-1) (LEUPRO) and 1.5 g · kg(-1) · d(-1) (control). Stable isotope infusions (1-(13)C-leucine and 6,6-(2)H2-glucose), mass spectrometry-based metabolomics, and nitrogen balance methods were used to determine the effects of LEUPRO on whole-body branched-chain amino acid (BCAA) and glucose metabolism and protein turnover.
After exercise, LEUPRO increased BCAA levels in plasma (2.6-fold; 90% confidence limits = ×/÷ 1.1) and urine (2.8-fold; ×/÷ 1.2) and increased products of BCAA metabolism plasma acylcarnitine C5 (3.0-fold; ×/÷ 0.9) and urinary leucine (3.6-fold; ×/÷ 1.3) and β-aminoisobutyrate (3.4-fold; ×/÷ 1.4), indicating that ingesting ~10 g leucine per hour during recovery exceeds the capacity to metabolize BCAA. Furthermore, LEUPRO increased leucine oxidation (5.6-fold; ×/÷ 1.1) and nonoxidative disposal (4.8-fold; ×/÷ 1.1) and left leucine balance positive relative to control. With the exception of day 1 (LEUPRO = 17 ± 20 mg N · kg(-1), control = -90 ± 44 mg N · kg(-1)), subsequent (days 2-5) nitrogen balance was positive for both conditions (LEUPRO = 130 ± 110 mg N · kg(-1), control = 111 ± 86 mg N · kg(-1)). Compared with control feeding, LEUPRO lowered the serum creatine kinase concentration by 21%-25% (90% confidence limits = ± 14%), but the effect on sprint power was trivial (day 4 = 0.4% ± 1.0%, day 6 = -0.3% ± 1.0%).
Postexercise protein-leucine supplementation saturates BCAA metabolism and attenuates tissue damage, but effects on subsequent intense endurance performance may be inconsequential under conditions of positive daily nitrogen balance.
本研究旨在确定运动后蛋白质-亮氨酸与 CHO-脂质共摄入对随后高强度耐力表现的影响,并使用稳定同位素方法和代谢组学来研究候选机制。
在这项双盲、随机、交叉研究中,12 名男性自行车运动员在 6 天的训练阶段(剧烈间歇、恢复、重复冲刺表现骑行)中,在运动后 1-3 小时内分别摄入亮氨酸/蛋白质/CHO/脂肪补充剂(LEUPRO 7.5/20/89/22 g·h(-1))或等热量 CHO/脂肪对照(119/22 g·h(-1))。每天的蛋白质摄入量固定在 1.9 g·kg(-1)·d(-1)(LEUPRO)和 1.5 g·kg(-1)·d(-1)(对照)。稳定同位素输注(1-(13)C-亮氨酸和 6,6-(2)H2-葡萄糖)、基于质谱的代谢组学和氮平衡方法用于确定 LEUPRO 对全身支链氨基酸(BCAA)和葡萄糖代谢以及蛋白质周转的影响。
运动后,LEUPRO 增加了血浆(2.6 倍;90%置信区间=×/÷1.1)和尿液(2.8 倍;×/÷1.2)中的 BCAA 水平,并增加了 BCAA 代谢产物血浆酰基肉碱 C5(3.0 倍;×/÷0.9)和尿液亮氨酸(3.6 倍;×/÷1.3)和β-氨基异丁酸(3.4 倍;×/÷1.4),表明在恢复期间每小时摄入约 10 克亮氨酸超过了代谢 BCAA 的能力。此外,LEUPRO 增加了亮氨酸氧化(5.6 倍;×/÷1.1)和非氧化处置(4.8 倍;×/÷1.1),并使亮氨酸平衡相对于对照呈正平衡。除第 1 天(LEUPRO=17±20 mg N·kg(-1),对照=-90±44 mg N·kg(-1))外,随后的(第 2-5 天)氮平衡在两种情况下均为正(LEUPRO=130±110 mg N·kg(-1),对照=111±86 mg N·kg(-1))。与对照喂养相比,LEUPRO 使血清肌酸激酶浓度降低 21%-25%(90%置信区间=±14%),但对冲刺能力的影响微不足道(第 4 天=0.4%±1.0%,第 6 天=-0.3%±1.0%)。
运动后蛋白质-亮氨酸补充可使 BCAA 代谢饱和,并减轻组织损伤,但在每日氮平衡为正的情况下,对随后的高强度耐力表现的影响可能微不足道。